Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
levonorgestrel androgen receptor small molecule NA drugbank Endometriosis[MeSHID:D004715]
Pregnancy[MeSHID:D011247]
Patient Discharge[MeSHID:D010351]
Coitus[MeSHID:D003075]
Menorrhagia[MeSHID:D008595]
Endometrial Hyperplasia[MeSHID:D004714]
Off-Label Use[MeSHID:D056687]
Unmarried[MeSHID:D012847]
Osteoporosis[MeSHID:D010024]
Prescription procedure[MeSHID:D055656]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational binder
levonorgestrel estrogen receptor alpha small molecule NA drugbank , DGIDB Endometriosis[MeSHID:D004715]
Pregnancy[MeSHID:D011247]
Patient Discharge[MeSHID:D010351]
Coitus[MeSHID:D003075]
Menorrhagia[MeSHID:D008595]
Endometrial Hyperplasia[MeSHID:D004714]
Off-Label Use[MeSHID:D056687]
Unmarried[MeSHID:D012847]
Osteoporosis[MeSHID:D010024]
Prescription procedure[MeSHID:D055656]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.06 approved,investigational unknown
levonorgestrel glucocorticoid receptor small molecule NA drugbank Endometriosis[MeSHID:D004715]
Pregnancy[MeSHID:D011247]
Patient Discharge[MeSHID:D010351]
Coitus[MeSHID:D003075]
Menorrhagia[MeSHID:D008595]
Endometrial Hyperplasia[MeSHID:D004714]
Off-Label Use[MeSHID:D056687]
Unmarried[MeSHID:D012847]
Osteoporosis[MeSHID:D010024]
Prescription procedure[MeSHID:D055656]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational binder
levonorgestrel progesterone receptor small molecule Successful target TTD , drugbank , DGIDB Endometriosis[MeSHID:D004715]
Pregnancy[MeSHID:D011247]
Patient Discharge[MeSHID:D010351]
Coitus[MeSHID:D003075]
Menorrhagia[MeSHID:D008595]
Endometrial Hyperplasia[MeSHID:D004714]
Off-Label Use[MeSHID:D056687]
Unmarried[MeSHID:D012847]
Osteoporosis[MeSHID:D010024]
Prescription procedure[MeSHID:D055656]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.17 approved,investigational modulator
levonorgestrel progesterone receptor small molecule Successful target TTD , drugbank , DGIDB Endometriosis[MeSHID:D004715]
Pregnancy[MeSHID:D011247]
Patient Discharge[MeSHID:D010351]
Coitus[MeSHID:D003075]
Menorrhagia[MeSHID:D008595]
Endometrial Hyperplasia[MeSHID:D004714]
Off-Label Use[MeSHID:D056687]
Unmarried[MeSHID:D012847]
Osteoporosis[MeSHID:D010024]
Prescription procedure[MeSHID:D055656]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.17 approved,investigational modulator,agonist
levonorgestrel sex hormone-binding globulin small molecule NA drugbank Endometriosis[MeSHID:D004715]
Pregnancy[MeSHID:D011247]
Patient Discharge[MeSHID:D010351]
Coitus[MeSHID:D003075]
Menorrhagia[MeSHID:D008595]
Endometrial Hyperplasia[MeSHID:D004714]
Off-Label Use[MeSHID:D056687]
Unmarried[MeSHID:D012847]
Osteoporosis[MeSHID:D010024]
Prescription procedure[MeSHID:D055656]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor,binder
levonorgestrel 3-oxo-5-alpha-steroid 4-dehydrogenase 1 small molecule NA drugbank , DGIDB Endometriosis[MeSHID:D004715]
Pregnancy[MeSHID:D011247]
Patient Discharge[MeSHID:D010351]
Coitus[MeSHID:D003075]
Menorrhagia[MeSHID:D008595]
Endometrial Hyperplasia[MeSHID:D004714]
Off-Label Use[MeSHID:D056687]
Unmarried[MeSHID:D012847]
Osteoporosis[MeSHID:D010024]
Prescription procedure[MeSHID:D055656]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 16.97 approved,investigational inhibitor
click here to return to the previous page